Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

FIBRINOGEN - ANVISA Registration 82444370184

Access comprehensive regulatory information for FIBRINOGEN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 82444370184 and manufactured by SHENZHEN DYMIND BIOTECHNOLOGY CO., LTD. The registration is held by Enzytec Biotecnologia Ltda. with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including BIOSYSTEMS S.A., ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
82444370184
Registration Details
ANVISA Registration Number: 82444370184
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Kit de Teste de Fibrinogênio (Método de Clauss Modificado)
Risk Class II

Registration Details

82444370184

25351445849202435

07214566000165

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Jan 27, 2025

VIGENTE

09/18/2025 19:00:01